企业精神
The spirit of enterprise
求精不求量，做专不做广
Strive for quality excellence over quantity, Make industry professional over extensive
天华制药，二十多年来，坚持“抓主业弃旁枝”的经营原则，专注于中药种植及提取。目前，年生产中药提取物1000余吨，加工中药材10000吨，年产值达5亿元。主要产品有金银花提取物、连翘提取物、金银花连翘提取物、黄芩提取物、银杏叶提取物、丹参酮提取物等产品。种植和经营大宗的中药材（金银花、连翘、黄芩、丹参等），销往全国50多个大中城市。
Over the past 20 years, Tianhua Pharmaceuticals has adhered to the business principle of “seeking major business and ridding insignificant ones”, and specialized in traditional Chinese herb medicine plantation and extraction. At present, we produce over 1,000 tons of Traditional Chinese herb medicine extract, and process 10,000 tons of traditional Chinese herb medicines each year, and the annual production value reaches 500 million yuan. Our main products include lonicera japonica extract, fructus forsythia extract, scutellaria baicalensis extract, ginkgo leaf extract, tanshinone extract, etc. We plant and operate bulk traditional Chinese herb medicines (lonicera japonica, fructus forsythia, scutellaria baicalensis, tanshinone, etc.) which are sold to over 50 large and medium-sized cities.
种植基地及产品系列
Planting base and Product Range
天华制药以沂蒙山丰富的地产中药资源优势为依托，建立了18000亩全国唯一的金银花药源基地，5000亩丹参和黄芩GAP基地，并分别于2009年和2011年通过了CFDA的GAP认证，为企业的专业化道路和长远发展奠定了良好的物质基础。
Relying on the rich pharmaceutical native herbs resources of Yimeng mountain, Tianhua Pharmaceutical established the only drug source base of Lonicera japonica in China, which is 18,000 acres, and 5,000 acres of Salvia miltiorrhiza, Scutellaria baicalensis base. These bases respectively are GAP certified by the CFDA in 2009 and 2011and create a good foundation for specialization and long-term development of our company.